EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study

Giovanni Grandi, Claudia Piombino, Giovanna Sighinolfi, Elena Barbieri, Marta Venturelli, Chiara Melotti, Rebecca Lippi Bruni, Valentina Grisendi, Riccardo Cuoghi Costantini, Mina Grippa, Emma Zattarin, Elena Tenedini und 9 weitere

Familial Cancer · 14.05.2026 · 25 (2)

DOI: 10.1007/s10689-026-00570-3 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Familial Cancer, online erschienen am 14.05.2026. Verfasst von Giovanni Grandi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy. giovanni.grandi@unimore.it. Hauptthemen laut MEDLINE: BRCA1 Protein, Glucose Intolerance, BRCA2 Protein. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Modena e Reggio Emilia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Estrogens exert a beneficial effect on metabolism. Women carrying BRCA likely pathogenic/pathogenic variants (LP/PV) are at increased risk of premature menopause and may therefore be at higher risk of developing metabolic disorders later in life. In this single-center prospective cohort study, we investigated whether the specific BRCA mutation ( BRCA 1 vs. BRCA 2) has a differential impact on metabolism in women.

Methods

Eligible participants were BRCA LP/PV carriers who were premenopausal or underwent menopause –either natural or iatrogenic– within the 5 years prior to enrollment. Blood samples for lipid and glucose panels were obtained every 6 months, for a total of four time points. Body composition variables were evaluated at baseline and at the final follow-up using bioimpedance analysis. Glucose tolerance was assessed using the homeostatic model assessment for insulin resistance (HOMA-IR). Associations between lipid and glucose profile and patient characteristics were evaluated using univariable and multivariable linear regression models.

Results

Fifty-seven BRCA1 and 58 BRCA2 LP/PV carriers were included in the final analysis. At baseline, BRCA1 LP/PV carriers had a higher body mass index (BMI) (27.3 vs. 24.6 kg/m 2 , p = 0.01) and higher fat mass (27.3 vs. 21.9 kg, p = 0.013) than BRCA2 LP/PV carriers. Insulin levels and HOMA-IR were consistently higher in BRCA1 than in BRCA2 LP/PV carriers at all time points, and this difference was not attributable to age, BMI, menopausal status, risk-reducing salpingo-oophorectomy, previous chemotherapy or use of cholesterol-lowering agents. The lipid profile was similar between the groups, although BRCA1 LP/PV carriers showed a tendency toward a less favorable profile (higher LDL and lower HDL).

Conclusions

These prospective results suggest that BRCA1 LP/PV carriers might have impaired glucose tolerance and a greater tendency toward insulin resistance compared with BRCA2 LP/PV carriers: this first report needs further independent confirmations from other cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinGlucose IntoleranceBRCA2 ProteinHumansFemaleProspective StudiesMiddle AgedAdultInsulin ResistanceMutationBlood GlucoseBody Mass Index

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, humanBlood Glucose

Autor:innen und Institutionen

  • Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy. giovanni.grandi@unimore.it.
  • Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy. giovanni.grandi@unimore.it.
  • Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Division of Oncology, Department of Oncology and Haematology, Azienda Ospedaliero- Universitaria di Modena, Modena, Italy.
  • Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Unit of Statistical and Methodological Support to Clinical Research, Azienda Ospedaliero- Universitaria di Modena, Modena, Italy.

Förderung

  • Università degli Studi di Modena e Reggio Emilia

Zitieren

APA

Grandi, G., Piombino, C., Sighinolfi, G., Barbieri, E., Venturelli, M., Melotti, C., Lippi Bruni, R., Grisendi, V., Cuoghi Costantini, R., Grippa, M., Zattarin, E., Tenedini, E., Razzaboni, E., Brigante, G., D'Amico, R., Nanni, B., Menozzi, R., Cortesi, L., Dominici, M., …, & Toss, A. (2026). Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study. Familial Cancer, 25(2). https://doi.org/10.1007/s10689-026-00570-3

Vancouver

Grandi G, Piombino C, Sighinolfi G, Barbieri E, Venturelli M, Melotti C, et al. Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study. Familial Cancer. 2026;25(2). doi:10.1007/s10689-026-00570-3

BibTeX
@article{Grandi2026,
  author = {Grandi, Giovanni and Piombino, Claudia and Sighinolfi, Giovanna and Barbieri, Elena and Venturelli, Marta and Melotti, Chiara and Lippi Bruni, Rebecca and Grisendi, Valentina and Cuoghi Costantini, Riccardo and Grippa, Mina and Zattarin, Emma and Tenedini, Elena and Razzaboni, Elisabetta and Brigante, Giulia and D'Amico, Roberto and Nanni, Benedetta and Menozzi, Renata and Cortesi, Laura and Dominici, Massimo and La Marca, Antonio and Toss, Angela},
  title = {Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study},
  journal = {Familial Cancer},
  year = {2026},
  volume = {25},
  number = {2},
  doi = {10.1007/s10689-026-00570-3}
}
Kostenlos starten →